Critically ill Patients and Platelet-Derived Microparticles
Author:
Open Access
- 1 January 2015
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 22 (8) , 752-753
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 11 references indexed in Scilit:
- Clinical significance of procoagulant microparticlesJournal of Intensive Care, 2015
- Association of the Plasma Platelet-Derived Microparticles to Platelet Count Ratio with Hospital Mortality and Disseminated Intravascular Coagulopathy in Critically Ill PatientsJournal of Atherosclerosis and Thrombosis, 2015
- Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational studyCritical Care, 2014
- The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancyPlatelets, 2011
- Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortalityIntensive Care Medicine, 2009
- Cell-derived microparticles in haemostasis and vascular medicineThrombosis and Haemostasis, 2009
- Assessment of an ELISA Kit for Platelet-Derived Microparticles by Joint Research at Many Institutes in JapanJournal of Atherosclerosis and Thrombosis, 2009
- Disseminated Intravascular Coagulation in SepsisChest, 2005
- Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]Critical Care, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003